Drugs Made In America Acquisition Corp. Rights (DMAAR) support and resistance · $1.8M cap
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
This page maps Drugs Made In America Acquisition Corp. Rights (DMAAR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
DMAAR income-statement cache is thin, so levels here lean on the stock page until the next filing lands.
DMAAR currently screens at market cap $1.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new DMAAR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the DMAAR quote page for the session range and the stock page for the full model.
Not investment advice.